New Clinical Trial with Andwin, Syneos & Philip Morris
Filed with ASX · · 3 pages · English
Story so far
Earlier from Conneqt Health
- Notice of Extraordinary General Meeting/Proxy Form
- Results of CDXO and November Options Exercise Conversions
- Appendix 4C and Quarterly Activities Report
- Manufacturing Agreement with Fenda Technology for CONNEQT
- Clinical Trial Contract Expansion & Increases with Bayer AG
Later from Conneqt Health
- Mobvoi launches TicWatch GTH Pro with Arty
- FDA Update for CONNEQT Companion App
- CardieX Submits FDA Application for CONNEQT Pulse
- CardieX Corporate Investor Presentation
- CardieX Completes Placement & Intended Launch of SPP
Follow Conneqt Health into a list and get an email when it puts out news.
Follow Conneqt Health